Intraperitoneal Floxuridine in Gastric Carcinoma



Status:Archived
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011

Use our guide to learn which trials are right for you!


Patients undergoing curative resection for gastric cancer have been shown to benefit from
postoperative chemotherapy with 5-fluoruracil + leucovorin, and radiation in an Intergroup
Study (INT116). However, both local and distal relapses still occur in 50% at 3 years. This
study is based on the hypothesis that 2 cycles (of 3 days each 2 weeks apart) of
intraperitoneal FUDR (floxuridine), followed by the above treatment will improve outcome.



We found this trial at
2
sites
550 1st Ave
New York, New York 10016
(212) 263-7300
New York University Langone Medical Center NYU NYU Langone Medical Center, a world-class, patient-centered, integrated,...
?
mi
from
New York, NY
Click here to add this to my saved trials
1983 Marengo St
Los Angeles, California 90033
(323) 226-2622
Los Angeles County-USC Medical Center The origins of LAC+USC Medical Center date back to 1878,...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials